Clinical Trials Browser

Phase 2 × SAR125844 × Tumor-Agnostic × Clear all

NCT02435121 2016-03-23

A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

Phase 2 Completed

Neoplasms